cancer

No Image

OneMedRadio: ADVENTRX Hosts First Annual Sickle Cell Disease Therapeutics Conference

September 14, 2012 OneMedPlace Team 0

September is Sickle Cell Awareness Month, a time when the medical community will gather with the patient population in the hopes of advancing research in this significant unmet medical need. One company, ADVENTRX Pharmaceuticals [NYSE: ANX], is attempting to engage the investor community and the sector’s most promising drug developers through the First Annual Sickle Cell Disease Therapeutics Conference, taking place September 19th, 2012 in New York City.

No Image

Bulls, Bears: 3 Promising Stocks in Metastatic Cancer

September 5, 2012 OneMedPlace Team 1

In this special series, we explore the state of select public companies operating in a particularly intriguing area of life sciences. This week, we look at metastatic cancer, an area of significant unmet need. These companies, including OncoSec Medical, are having success with their innovative approaches to treating metastatic cancer, and are seeing results in their performance int he public markets.